| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |